Cronos (CRON) Non-Current Assets (2016 - 2026)
Cronos' (CRON) quarterly Non-Current Assets came in at $244.2 million in Q1 2026, up 3.82% year-on-year from $235.2 million in Q1 2025, and down 3.49% quarter-over-quarter from $253.1 million in Q4 2025.
Cronos (CRON) Non-Current Assets (2016 - 2026) Analysis & Trends
Cronos' Non-Current Assets history runs 11 years deep, the most recent figure standing at $244.2 million for Q1 2026.
- On a quarterly basis, Non-Current Assets rose 3.82% year-over-year to $244.2 million in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 18.37% increase from a year earlier, with the FY2025 full-year figure at $253.1 million, up 9.93% from the prior year.
- Non-Current Assets slipped to $244.2 million in Q1 2026 per CRON's latest filing, from $253.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $307.6 million in Q1 2022 and bottomed at $99.2 million in Q4 2023.
- The 5-year median for Non-Current Assets is $243.4 million (2023), against an average of $225.0 million.
- Across the five-year window, Non-Current Assets sank 45.16% in 2022 and soared 131.99% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $104.2 million in 2022, then fell by 4.8% to $99.2 million in 2023, then surged by 131.99% to $230.2 million in 2024, then gained by 9.93% to $253.1 million in 2025, then fell by 3.49% to $244.2 million in 2026.
- Per Business Quant, the three latest CRON Non-Current Assets figures stand at $244.2 million (Q1 2026), $253.1 million (Q4 2025), and $256.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 244.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 244.23 Mn |
| Dec 31, 2025 | 253.05 Mn |
| Sep 30, 2025 | 256.26 Mn |
| Jun 30, 2025 | 248.08 Mn |
| Mar 31, 2025 | 235.25 Mn |
| Dec 31, 2024 | 230.20 Mn |
| Sep 30, 2024 | 224.96 Mn |
| Jun 30, 2024 | 155.77 Mn |
| Mar 31, 2024 | 166.32 Mn |
| Dec 31, 2023 | 99.23 Mn |
| Sep 30, 2023 | 231.73 Mn |
| Jun 30, 2023 | 243.57 Mn |
| Mar 31, 2023 | 243.44 Mn |
| Dec 31, 2022 | 104.23 Mn |
| Sep 30, 2022 | 274.15 Mn |
| Jun 30, 2022 | 306.16 Mn |
| Mar 31, 2022 | 307.60 Mn |
| Dec 31, 2021 | 125.78 Mn |
| Sep 30, 2021 | 431.34 Mn |
| Jun 30, 2021 | 440.41 Mn |